Home › Companies › Pacira Biosciences, Inc. › 2025-2026

Pacira Biosciences, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Pacira Biosciences, Inc.’s Form 8-K, filed June 11, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 11Reported items
  • 278Asset managers
  • 3,765Fund votes
  • June 9, 2026Meeting date

Results at a glance

Meeting of June 9, 2026: 10 items on Pacira Biosciences, Inc.’s Form 8-K, filed June 11, 2026: 10 without a stated outcome.

Contested election

Nominees the filing reports as not elected, and nominees under 80% of the votes cast.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Pacira Biosciences, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Pacira Biosciences, Inc.

These tallies are Pacira Biosciences, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Pacira Biosciences, Inc. — official shareholder meeting results, meeting held June 9, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Christopher J. Christie 24,963,961---- 7,675,321-- 76%Not verified—
Elect Director: Samit Hirawat 27,950,304---- 4,688,937-- 86%Not verified—
Elect Director: Thomas Wiggans 28,044,841---- 4,594,438-- 86%Not verified—
Elect Director: Oliver Benton Curtis III 4,614,368---- 28,024,482-- 14%Not verified—
Elect Director: Eric de Armas 4,861,350---- 27,777,500-- 15%Not verified—
Elect Director: Christopher Dennis 4,430,726---- 28,208,124-- 14%Not verified—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 32,908,044138,24649,702 ---- 99.5%Not verified—
3. Advisory vote to approve the compensation of the Company's named executive officers 19,513,22413,073,32157,010 --452,437 60%Not verified—
4. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan 14,178,41818,405,75459,383 --452,437 44%Not verified—
5. Approval of the Company's Amended and Restated 2014 Employee Stock Purchase Plan 29,089,9283,497,65355,974 --452,437 89%Not verified—

Source: Pacira Biosciences, Inc., Form 8-K, filed with the SEC on June 11, 2026 — read the filing on EDGAR.

How asset managers voted at the Pacira Biosciences, Inc. 2025-2026 meeting

Each item below shows how the 278 asset managers that disclosed a Pacira Biosciences, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Pacira Biosciences, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Samit Hirawat

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD
FOR: 27,950,304WITHHELD: 4,688,937
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: Samit Hirawat

Pacira Biosciences, Inc.’s own tally for this item (“Elect Director: Samit Hirawat”): 27,950,304 for, 4,688,937 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 14,889,433 for, 1,162,252 withheld, 2,121,082 not voted.

FOR
FOR: 14,889,433WITHHOLD: 1,162,252NOT VOTED: 2,121,082
Largest asset managers voting on “Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stoc” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,584,3550 00For
BlackRock3,303,0170 00For
IMPAX FUNDS SERIES TRUST I750,0270 00For
Charles Schwab662,0550 00For
Fidelity916,6840 00For
State Street859,4220 00For
American Century4900 0802,513Withhold
Dimensional659,6690 00For
EA Series Trust192,5390 0177,889Mixed
DWS355,6110 00For
World Funds Trust269,9550 00For
Pacer Funds Trust234,6230 00For
Hartford112,9050 00For
SEI105,1400 00For
ADVISORS' INNER CIRCLE FUND72,3000 00For
James Alpha Funds Trust00 0138,400Withhold
Columbia Threadneedle121,6550 00For
Russell Investments57,3480 00For
Victory Capital99,5400 00For
EXCHANGE TRADED CONCEPTS TRUST98,6240 00For
NYLIM VP FUNDS TRUST47,7440 00For
Equitable93,1910 00For
Lincoln Financial44,0970 00For
Principal Exchange-Traded Funds85,1910 00For
TIAA84,5580 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

2. Elect Director: Thomas Wiggans

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD
FOR: 28,044,841WITHHELD: 4,594,438
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: Tom Wiggans

Pacira Biosciences, Inc.’s own tally for this item (“Elect Director: Thomas Wiggans”): 28,044,841 for, 4,594,438 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 14,926,602 for, 1,125,083 withheld, 2,121,082 not voted.

FOR
FOR: 14,926,602WITHHOLD: 1,125,083NOT VOTED: 2,121,082
Largest asset managers voting on “Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stoc” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,584,3550 00For
BlackRock3,303,0170 00For
IMPAX FUNDS SERIES TRUST I750,0270 00For
Charles Schwab662,0550 00For
Fidelity916,6840 00For
State Street859,4220 00For
American Century4900 0802,513Withhold
Dimensional659,6690 00For
EA Series Trust192,5390 0177,889Mixed
DWS355,6110 00For
World Funds Trust269,9550 00For
Pacer Funds Trust234,6230 00For
Hartford112,9050 00For
SEI105,1400 00For
ADVISORS' INNER CIRCLE FUND72,3000 00For
James Alpha Funds Trust00 0138,400Withhold
Columbia Threadneedle121,6550 00For
Russell Investments57,3480 00For
Victory Capital99,5400 00For
EXCHANGE TRADED CONCEPTS TRUST98,6240 00For
NYLIM VP FUNDS TRUST47,7440 00For
Equitable93,1910 00For
Lincoln Financial44,0970 00For
Principal Exchange-Traded Funds85,1910 00For
TIAA84,5580 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

3. Elect Director: Christopher Dennis

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

14% Plurality election · of votes cast

14%WITHHELD
FOR: 4,430,726WITHHELD: 28,208,124
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Christopher Dennis

Pacira Biosciences, Inc.’s own tally for this item (“Elect Director: Christopher Dennis”): 4,430,726 for, 28,208,124 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 14% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 984,363 for, 15,067,322 withheld, 2,121,082 not voted.

WITHHOLD
FOR: 984,363WITHHOLD: 15,067,322NOT VOTED: 2,121,082
Largest asset managers voting on “Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stoc” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 04,584,355Withhold
BlackRock00 03,303,017Withhold
IMPAX FUNDS SERIES TRUST I00 0750,027Withhold
Charles Schwab00 0662,055Withhold
Fidelity00 0916,684Withhold
State Street00 0859,422Withhold
American Century802,5130 0490For
Dimensional00 0659,669Withhold
EA Series Trust00 0370,428Withhold
DWS00 0355,611Withhold
World Funds Trust00 0269,955Withhold
Pacer Funds Trust00 0234,623Withhold
Hartford00 0112,905Withhold
SEI00 0105,140Withhold
ADVISORS' INNER CIRCLE FUND00 072,300Withhold
James Alpha Funds Trust138,4000 00For
Columbia Threadneedle00 0121,655Withhold
Russell Investments00 057,348Withhold
Victory Capital00 099,540Withhold
EXCHANGE TRADED CONCEPTS TRUST00 098,624Withhold
NYLIM VP FUNDS TRUST00 047,744Withhold
Equitable00 093,191Withhold
Lincoln Financial00 044,097Withhold
Principal Exchange-Traded Funds00 085,191Withhold
TIAA00 084,558Withhold

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

4. Elect Director: Eric de Armas

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

15% Plurality election · of votes cast

FOR 15%WITHHELD
FOR: 4,861,350WITHHELD: 27,777,500
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas

Pacira Biosciences, Inc.’s own tally for this item (“Elect Director: Eric de Armas”): 4,861,350 for, 27,777,500 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 15% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 1,165,884 for, 14,885,801 withheld, 2,121,082 not voted.

WITHHOLD
FOR: 1,165,884WITHHOLD: 14,885,801NOT VOTED: 2,121,082
Largest asset managers voting on “Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stoc” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 04,584,355Withhold
BlackRock159,7110 03,143,306Withhold
IMPAX FUNDS SERIES TRUST I00 0750,027Withhold
Charles Schwab00 0662,055Withhold
Fidelity27,8550 0888,829Withhold
State Street00 0859,422Withhold
American Century802,5130 0490For
Dimensional00 0659,669Withhold
EA Series Trust00 0370,428Withhold
DWS00 0355,611Withhold
World Funds Trust00 0269,955Withhold
Pacer Funds Trust00 0234,623Withhold
Hartford00 0112,905Withhold
SEI00 0105,140Withhold
ADVISORS' INNER CIRCLE FUND00 072,300Withhold
James Alpha Funds Trust138,4000 00For
Columbia Threadneedle00 0121,655Withhold
Russell Investments00 057,348Withhold
Victory Capital00 099,540Withhold
EXCHANGE TRADED CONCEPTS TRUST00 098,624Withhold
NYLIM VP FUNDS TRUST00 047,744Withhold
Equitable00 093,191Withhold
Lincoln Financial00 044,097Withhold
Principal Exchange-Traded Funds00 085,191Withhold
TIAA00 084,558Withhold

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

5. Elect Director: Oliver Benton Curtis III

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

14% Plurality election · of votes cast

FOR 14%WITHHELD
FOR: 4,614,368WITHHELD: 28,024,482
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III

Pacira Biosciences, Inc.’s own tally for this item (“Elect Director: Oliver Benton Curtis III”): 4,614,368 for, 28,024,482 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 14% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 984,363 for, 15,067,322 withheld, 2,121,082 not voted.

WITHHOLD
FOR: 984,363WITHHOLD: 15,067,322NOT VOTED: 2,121,082
Largest asset managers voting on “Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stoc” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 04,584,355Withhold
BlackRock00 03,303,017Withhold
IMPAX FUNDS SERIES TRUST I00 0750,027Withhold
Charles Schwab00 0662,055Withhold
Fidelity00 0916,684Withhold
State Street00 0859,422Withhold
American Century802,5130 0490For
Dimensional00 0659,669Withhold
EA Series Trust00 0370,428Withhold
DWS00 0355,611Withhold
World Funds Trust00 0269,955Withhold
Pacer Funds Trust00 0234,623Withhold
Hartford00 0112,905Withhold
SEI00 0105,140Withhold
ADVISORS' INNER CIRCLE FUND00 072,300Withhold
James Alpha Funds Trust138,4000 00For
Columbia Threadneedle00 0121,655Withhold
Russell Investments00 057,348Withhold
Victory Capital00 099,540Withhold
EXCHANGE TRADED CONCEPTS TRUST00 098,624Withhold
NYLIM VP FUNDS TRUST00 047,744Withhold
Equitable00 093,191Withhold
Lincoln Financial00 044,097Withhold
Principal Exchange-Traded Funds00 085,191Withhold
TIAA00 084,558Withhold

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

6. Elect Director: Christopher J. Christie

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD
FOR: 24,963,961WITHHELD: 7,675,321
Details: description as filed, official tally, votes by 84 asset managers

Description as filed by funds: Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: Christopher J. Christie

Pacira Biosciences, Inc.’s own tally for this item (“Elect Director: Christopher J. Christie”): 24,963,961 for, 7,675,321 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Pacira Biosciences, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “COMPANY NOMINEE OPPOSED BY DOMA: Christopher J. Christie” (7 managers, 332,408 withheld).

The 84 asset managers below reported 14,060,763 for, 1,658,514 withheld, 2,121,082 not voted.

FOR
FOR: 14,060,763WITHHOLD: 1,658,514NOT VOTED: 2,121,082
Largest asset managers voting on “Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stoc” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,584,3550 00For
BlackRock3,143,3060 00For
IMPAX FUNDS SERIES TRUST I750,0270 00For
Charles Schwab662,0550 00For
Fidelity888,8290 027,855For
State Street859,4220 00For
American Century4900 0802,513Withhold
Dimensional00 0659,669Withhold
EA Series Trust370,4280 00For
DWS355,6110 00For
World Funds Trust269,9550 00For
Pacer Funds Trust234,6230 00For
Hartford112,9050 00For
SEI105,1400 00For
ADVISORS' INNER CIRCLE FUND72,3000 00For
Columbia Threadneedle121,6550 00For
Russell Investments57,3480 00For
Victory Capital99,5400 00For
EXCHANGE TRADED CONCEPTS TRUST98,6240 00For
NYLIM VP FUNDS TRUST47,7440 00For
Equitable93,1910 00For
Lincoln Financial37,6040 06,493Mixed
Principal Exchange-Traded Funds85,1910 00For
TIAA84,5580 00For
Jackson National63,9440 011,153Mixed

Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.

7. 5. Approval of the Company's Amended and Restated 2014 Employee Stock Purchase Plan

Outcome not verifiedFund totals may overlapCOMPENSATIONReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 29,089,928AGAINST: 3,497,653
Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: APPROVAL OF OUR AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN.

Pacira Biosciences, Inc.’s own tally for this item (“5. Approval of the Company's Amended and Restated 2014 Employee Stock Purchase Plan”): 29,089,928 for, 3,497,653 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 87 asset managers voting on “APPROVAL OF OUR AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN.” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,584,3550 00For
BlackRock3,303,0170 00For
IMPAX FUNDS SERIES TRUST I750,0270 00For
Charles Schwab662,0550 00For
Fidelity916,6840 00For
State Street859,4220 00For
American Century803,0030 00For
Dimensional659,6690 00For
EA Series Trust370,4280 00For
DWS355,6110 00For
World Funds Trust269,9550 00For
Pacer Funds Trust234,6230 00For
Hartford112,9050 00For
SEI105,1400 00For
ADVISORS' INNER CIRCLE FUND72,3000 00For
James Alpha Funds Trust0138,400 00Against
Columbia Threadneedle121,6550 00For
Russell Investments57,3480 00For
Victory Capital99,5400 00For
EXCHANGE TRADED CONCEPTS TRUST98,6240 00For
NYLIM VP FUNDS TRUST47,7440 00For
Equitable93,1910 00For
Lincoln Financial44,0970 00For
Principal Exchange-Traded Funds85,1910 00For
TIAA84,5580 00For

Fund voting reports, all 87 managers: 15,861,317 for, 190,368 against, 2,121,082 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “APPROVAL OF OUR AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN.” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Doma Perpetual Capital Management LLC02,769,053 00Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma43,0880 00For
Vident Advisory, LLC3,5470 3,5470Mixed

Institutional-manager reports, all 3 managers: 46,635 for, 2,769,053 against, 3,547 abstained, 43,088 not voted.

8. 4. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan

Outcome not verifiedCOMPENSATIONReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

44% Majority: no · of votes cast

FOR 44%AGAINST
FOR: 14,178,418AGAINST: 18,405,754
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.

Pacira Biosciences, Inc.’s own tally for this item (“4. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan”): 14,178,418 for, 18,405,754 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 44% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 9,940,112 for, 6,084,009 against, 3,547 abstained, 2,121,082 not voted.

FORAGAINST
FOR: 9,940,112AGAINST: 6,084,009ABSTAIN: 3,547NOT VOTED: 2,121,082
Largest asset managers voting on “APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard2,808,7341,775,622 00Mixed
BlackRock3,143,306159,711 00For
IMPAX FUNDS SERIES TRUST I750,0270 00For
Charles Schwab0662,055 00Against
Fidelity798,367118,317 00Mixed
State Street857,0822,340 00For
American Century802,513490 00For
Dimensional0659,669 00Against
EA Series Trust177,889192,539 00Mixed
DWS0355,611 00Against
World Funds Trust0269,955 00Against
Pacer Funds Trust0234,623 00Against
Hartford112,9050 00For
SEI0105,140 00Against
ADVISORS' INNER CIRCLE FUND072,300 00Against
James Alpha Funds Trust0138,400 00Against
Columbia Threadneedle0121,655 00Against
Russell Investments057,348 00Against
Victory Capital099,540 00Against
EXCHANGE TRADED CONCEPTS TRUST098,624 00Against
NYLIM VP FUNDS TRUST47,7440 00For
Equitable58,19135,000 00Mixed
Lincoln Financial26,87517,222 00Mixed
Principal Exchange-Traded Funds085,191 00Against
TIAA084,558 00Against

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

9. Approval, on an advisory basis, of the compensation of our named executive officers.

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

77% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: votes by 269 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 82 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,584,3550 00For
BlackRock3,143,3060 00For
Fidelity798,36790,462 00Mixed
State Street858,3231,099 00For
IMPAX FUNDS SERIES TRUST I750,0270 00For
Charles Schwab662,0550 00For
Dimensional0659,669 00Against
EA Series Trust370,4280 00For
DWS0355,611 00Against
World Funds Trust269,9550 00For
Pacer Funds Trust234,6230 00For
Columbia Threadneedle0121,655 00Against
Hartford112,9050 00For
SEI105,1400 00For
Victory Capital099,540 00Against
EXCHANGE TRADED CONCEPTS TRUST098,624 00Against
Equitable58,19135,000 00Mixed
Principal Exchange-Traded Funds085,191 00Against
TIAA84,5580 00For
Jackson National63,94411,153 00Mixed
Invesco072,545 00Against
ADVISORS' INNER CIRCLE FUND72,3000 00For
Northern Trust068,980 00Against
QUANTITATIVE MASTER SERIES LLC66,4160 00For
Simplify Exchange Traded Funds60,6100 00For

Fund voting reports, all 82 managers: 12,717,822 for, 2,136,868 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 206 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street1,788,6591,899 00For
BlackRock1,434,60839,405 00For
GEODE CAPITAL MANAGEMENT, LLC925,0420 00For
IMPAX ASSET MANAGEMENT LLC750,0270 00For
Charles Schwab735,3390 00For
Wellington460,8160 00For
DE Shaw0427,335 00Against
Vanguard388,9512,615 00For
Invesco0388,079 00Against
Renaissance0356,674 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC350,1210 00For
LSV ASSET MANAGEMENT339,4000 00For
Hillsdale Investment Management Inc.0331,300 00Against
PRINCIPAL GLOBAL INVESTORS0284,752 00Against
Goldman Sachs279,3004,575 00For
Northern Trust0279,976 00Against
Victory Capital0237,700 00Against
MELLON INVESTMENTS Corp180,4440 00For
Two Sigma0166,545 00Against
SEI155,1010 00For
Dimensional0150,565 00Against
PUBLIC SECTOR PENSION INVESTMENT BOARD0139,248 00Against
J. Goldman & Co LP95,7500 00For
Fidelity095,232 00Against
Nuveen95,1590 00For

Institutional-manager reports, all 206 managers: 8,605,878 for, 4,168,580 against, 61 not voted. Showing the 25 largest; see all in the interactive database.

10. Approval, on an advisory basis, of the compensation of the Company's named executive officers.

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

70% Fund and manager reports combined; may count the same shares twice · no official result

FORNOT VOTED
Details: votes by 77 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 26 asset managers voting on “Approval, on an advisory basis, of the compensation of the Company's named executive officers.” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
American Century802,5130 00For
IMPAX FUNDS SERIES TRUST I00 00Not Voted
Charles Schwab00 00Not Voted
Vanguard00 00Not Voted
BlackRock0159,711 00Against
James Alpha Funds Trust0138,400 00Against
Hartford00 00Not Voted
SEI00 00Not Voted
ADVISORS' INNER CIRCLE FUND00 00Not Voted
Russell Investments00 00Not Voted
NYLIM VP FUNDS TRUST00 00Not Voted
Lincoln Financial00 00Not Voted
Fidelity027,855 00Against
Catholic Responsible Investments Funds00 00Not Voted
CLEARWATER INVESTMENT TRUST00 00Not Voted
MASTER INVESTMENT PORTFOLIO018,144 00Against
Global X00 00Not Voted
RBB FUND, INC.012,980 00Against
STERLING CAPITAL FUNDS00 00Not Voted
Brighthouse00 00Not Voted
TRUST FOR PROFESSIONAL MANAGERS3,1730 00For
Pacific Life3,1080 00For
Venerable Variable Insurance Trust00 00Not Voted
Meeder Funds00 00Not Voted
Nationwide00 00Not Voted

Fund voting reports, all 26 managers: 808,794 for, 357,090 against, 2,121,082 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 45 asset managers voting on “Approval, on an advisory basis, of the compensation of the Company's named executive officers.” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
American Century865,8760 00For
IMPAX ASSET MANAGEMENT LLC00 00Not Voted
Charles Schwab00 00Not Voted
Wellington00 00Not Voted
Renaissance00 00Not Voted
LSV ASSET MANAGEMENT00 00Not Voted
BlackRock0299,150 00Against
SEI00 00Not Voted
RICE HALL JAMES & ASSOCIATES, LLC00 00Not Voted
Universal-Investment-Gesellschaft mbH00 00Not Voted
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM00 00Not Voted
Russell Investments00 00Not Voted
NEW YORK STATE COMMON RETIREMENT FUND00 00Not Voted
Prudential/PGIM00 00Not Voted
Robeco Institutional Asset Management B.V.00 00Not Voted
AllianceBernstein00 00Not Voted
Rhumbline1,71536,342 00Against
WASHINGTON STATE INVESTMENT BOARD00 00Not Voted
BALYASNY ASSET MANAGEMENT L.P.00 00Not Voted
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM00 00Not Voted
BNY Mellon031,265 00Against
BANK OF AMERICA NA00 00Not Voted
MARSHALL WACE, LLP00 00Not Voted
Sterling Capital Management LLC00 00Not Voted
FIFTH THIRD BANK, NATIONAL ASSOCIATION00 00Not Voted

Institutional-manager reports, all 45 managers: 867,591 for, 375,352 against, 4,536 abstained, 3,499,953 not voted. Showing the 25 largest; see all in the interactive database.

11. 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 32,908,044AGAINST: 138,246
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Pacira Biosciences, Inc.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 32,908,044 for, 138,246 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 16,051,598 for, 88 against, 2,121,082 not voted.

FOR
FOR: 16,051,598AGAINST: 88NOT VOTED: 2,121,082
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at Pacira Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,584,3550 00For
BlackRock3,303,0170 00For
IMPAX FUNDS SERIES TRUST I750,0270 00For
Charles Schwab662,0550 00For
Fidelity916,6840 00For
State Street859,33488 00For
American Century803,0030 00For
Dimensional659,6690 00For
EA Series Trust370,4280 00For
DWS355,6110 00For
World Funds Trust269,9550 00For
Pacer Funds Trust234,6230 00For
Hartford112,9050 00For
SEI105,1400 00For
ADVISORS' INNER CIRCLE FUND72,3000 00For
James Alpha Funds Trust138,4000 00For
Columbia Threadneedle121,6550 00For
Russell Investments57,3480 00For
Victory Capital99,5400 00For
EXCHANGE TRADED CONCEPTS TRUST98,6240 00For
NYLIM VP FUNDS TRUST47,7440 00For
Equitable93,1910 00For
Lincoln Financial44,0970 00For
Principal Exchange-Traded Funds85,1910 00For
TIAA84,5580 00For

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

Largest Pacira Biosciences, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 39,347,924 shares outstanding at the time of that meeting.

Fund voting reports: top Pacira Biosciences, Inc. shareholders by shares voted on “APPROVAL OF OUR AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 12.13%
2BlackRock 8.39%
3IMPAX FUNDS SERIES TRUST I 3.81%
4Charles Schwab 3.37%
5Fidelity 2.33%
6State Street 2.18%
7American Century 2.04%
8Dimensional 1.68%
9EA Series Trust 0.94%
10DWS 0.90%
Institutional-manager reports: top Pacira Biosciences, Inc. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1State Street 4.55%
2BlackRock 3.75%
3GEODE CAPITAL MANAGEMENT, LLC 2.35%
4IMPAX ASSET MANAGEMENT LLC 1.91%
5Charles Schwab 1.87%
6Wellington 1.17%
7DE Shaw 1.09%
8Vanguard 1.00%
9Invesco 0.99%
10Renaissance 0.91%

Reported Pacira Biosciences, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Pacira Biosciences, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 17.12% 13F
Vanguard Group 12.23% 13F
Doma Perpetual Capital Management LLC 7.46% 13D
Pedro Escudero 7.46% 13D
Vanguard Portfolio Management 6.57% 13G
Dimensional Fund Advisors 5.24% 13F
D.E. Shaw 5.04% 13F
State Street 4.88% 13F
Renaissance Technologies 4.64% 13F
Goldman Sachs 3.99% 13F

Percentages above are of 39,347,924 shares outstanding, as reported by Pacira Biosciences, Inc. on its Form 10-Q dated April 29, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Pacira Biosciences, Inc.’s 10-Q dated April 29, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At Pacira Biosciences, Inc.'s shareholder meeting held June 9, 2026, in the 2025-2026 proxy season, 278 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,765 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Pacira Biosciences, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval, on an advisory basis, of the compensation of our named executive officers. — the reporting funds and managers cast 77% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Pacira Biosciences, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.